Drug Shortage Report for TOBRAMYCIN INJECTION USP

Last updated on 2022-03-03 History
Report ID 155947
Drug Identification Number 02502372
Brand name TOBRAMYCIN INJECTION USP
Common or Proper name TOBRAMYCIN FOR INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 25 VIALS
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-03-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-03-03 French Compare
v1 2022-03-03 English Compare

Showing 1 to 2 of 2